Hormone replacement therapy (HRT) is a powerful tool for managing symptoms of menopause and promoting overall health in postmenopausal women. However, many women find that their HRT regimen isn’t delivering the desired results, particularly when it comes to bone health. If you’re experiencing this, you might simply need more of the hormones you’re taking. In this blog post, we’ll explore the importance of optimizing hormone levels, especially estradiol, and why achieving the right balance is crucial for your health.
Estradiol, a form of estrogen, plays a vital role in women’s health, particularly in maintaining bone density. However, the research around optimal estradiol levels for specific health goals in postmenopausal women is limited. This lack of data has significant implications, especially for women who rely on HRT to protect their bones.
In developing our osteoporosis program, we consistently saw patients on low-dose HRT who were still losing bone mass. These women were shocked to learn that the estrogen they were taking wasn’t adequately protecting their bones. The problem wasn’t the estradiol itself; rather, it was the dosage. Research suggests that different tissues in the body respond to estradiol at different serum levels, and there may be significant variation from person to person in the levels necessary to achieve desired health outcomes.
While comprehensive studies examining the effects of varying estradiol levels on multiple health outcomes are lacking, we do have some compelling evidence related to bone health. Bone metabolism is easier to measure than other outcomes like mood, cognitive function, and cardiovascular health, so most of the available data focus on bone density.
A review of the SWAN (Study of Women's Health Across the Nation) bone study found that as women transitioned into menopause, their estradiol levels were strongly associated with bone mineral density. The study identified a threshold of 35 pg/ml as a tipping point for bone health. However, other studies on postmenopausal women suggest that higher estradiol levels—ranging from 70 to 90 pg/ml—are required to maintain bone density.
This level of estrogen is challenging to achieve with static HRT due to what’s known as the "physiologic ceiling" of hormone replacement. The body can only tolerate so much estradiol and progesterone at one time without causing side effects like breakthrough bleeding or increasing the risk of endometrial cancer. Therefore, the question becomes whether we can achieve our health goals using these hormones at static doses.
The evidence suggests that while low-dose HRT may reduce or eliminate hot flashes, it might not be enough to protect your bones. Several studies indicate that estradiol levels between 60 and 80 pg/ml are critical for bone turnover and osteoporosis prevention. This level coincides with the average estradiol level at the end of the early follicular phase of the menstrual cycle, but it’s still lower than the levels typically seen in the late follicular phase or the luteal phase.
Achieving these higher estradiol levels may be necessary to fully protect bone health, but doing so with static dosing is difficult due to the limitations in progesterone dosing, especially when administered orally. Even within these boundaries, we might be able to achieve serum levels that improve bone health. However, what about other tissues? We don’t yet know what estradiol levels are needed for optimal vascular, cardiac, and brain health.
The fear of estrogen has deterred much of the research needed to explore these nuances, which is why in our practice, we approach HRT through the lens of HealthSpan. We measure biomarkers to help us differentiate the function of various organs and determine the best course of action for each patient.
Each woman’s ability to tolerate higher levels of static HRT is likely to vary greatly. Regardless of how high we push these levels, we will still fall short of achieving true physiologic levels. On average, women see spikes of estradiol to 250 pg/ml in the late follicular phase and around 130 pg/ml in the luteal phase, with significant variation among individuals. Could it be that we need to achieve these levels to see the maximum benefits of HRT?
Reason #7 your hormones aren’t working for you could be that you simply don’t have enough to achieve your health goals. This doesn’t just apply to estradiol—progesterone and testosterone dosing also require careful consideration.
Progesterone dosing is particularly tricky. When using oral therapy, progesterone levels are challenging to measure, and when using topical preparations, they are impossible to measure in venous blood. This makes it difficult to determine the right dosage for each woman. Testosterone, on the other hand, is easier to measure, but clinical responses tend to vary.
Given these challenges, it may be worth considering whether we need to cycle hormones in replacement therapy, mimicking the natural hormonal fluctuations that occur before menopause. This approach could potentially help women achieve more balanced and effective hormone levels.
Cycling hormones in replacement therapy involves adjusting hormone levels to mimic the natural rise and fall of estrogen, progesterone, and testosterone that occurs during the menstrual cycle. This approach could help overcome the limitations of static dosing and achieve more physiologic levels of hormones, potentially providing greater benefits for bone health, cardiovascular health, cognitive function, and overall well-being.
While this approach is not yet widely adopted, it is a promising area of exploration for optimizing HRT. By cycling hormones, we might be able to better support the body’s natural rhythms and achieve a more comprehensive range of health benefits.
If your hormone replacement therapy isn’t delivering the results you’re looking for, the issue may be that you simply need more of the hormones you’re taking. Optimal dosing is critical, especially when it comes to estradiol, and achieving the right levels can have a significant impact on your bone health, heart health, brain function, and overall well-being.
Unfortunately, the research needed to determine the optimal estradiol levels for various tissues is still lacking. However, by working with a healthcare provider who understands the nuances of HRT and is willing to explore personalized dosing strategies, you can increase your chances of achieving the health outcomes you desire.
If your hormones aren’t working for you, it could be that you simply don’t have enough to achieve your health goals. Don’t settle for suboptimal results—consider whether your current HRT regimen might need an upgrade, and explore the potential benefits of higher hormone levels or cycling hormones in your replacement therapy. By taking a more personalized approach to HRT, you can better support your long-term health and well-being.
.jpg)
Access to proper care and personalized hormone replacement therapy (HRT) is crucial for women to fully benefit from its potential in optimizing health and relieving menopausal symptoms.
.svg){kind=icon}
.jpg)
Optimizing hormone replacement therapy (HRT) requires personalized care, regular monitoring, and the right combination of hormones, doses, and delivery methods to achieve the best health outcomes.
.jpg)
Rhythmic hormone replacement therapy, which mimics natural hormonal cycles, may offer greater health benefits than traditional static dosing, potentially improving outcomes for bone, breast, and cardiovascular health in postmenopausal women.
